by Sue Robbins | Feb 12, 2020 | Migraine
Children and adults with obesity who lose weight may experience a reduction in migraine frequency and severity, according to findings of a new study. By searching the PubMed/Medline database, the Web of Science (formerly known as the Institute for Scientific...
by Sue Robbins | Feb 11, 2020 | Migraine
Individuals who suffer from migraine headaches appear to have a hyper-excitable visual cortex researchers at the Universities of Birmingham and Lancaster suggest. Migraines are characterised as debilitating and persistent headaches, often accompanied by an increased...
by Sue Robbins | Feb 7, 2020 | Miscellaneous
Craniosacral therapy (CST) may have major therapeutic benefits to those suffering from chronic pain, a new literature review published in BMC Musculoskeletal Disorders found. The literature review examined randomized controlled trials for craniosacral therapy (CST) in...
by Sue Robbins | Feb 5, 2020 | Migraine
Adults with Migraine have new reason to be hopeful. 2019 saw FDA approval of new acute Migraine medications, and 2020 will be the year thousands of adults with Migraine with or without aura will get to try new meds like Ubrelvy (ubreogepant). Ubrelvy is an oral CGRP...
by Sue Robbins | Jan 27, 2020 | Migraine
Treatment with the orally administered, small-molecule calcitonin gene-related peptide receptor antagonist ubrogepant in patients with acute migraine has been associated with freedom from pain and the absence of the patient-determined most troublesome symptom compared...
